| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Fatemeh Karami | |
| Parvin Mehdipour | |||
| P2860 | cites work | Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G | Q21343014 |
| Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Q22000758 | ||
| Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1 | Q24321914 | ||
| Evidence of a founder BRCA1 mutation in Scotland | Q24649433 | ||
| BRCA1 and BRCA2 mutations in Scotland and Northern Ireland | Q24650826 | ||
| BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer | Q81359295 | ||
| [BRCA1 germ line mutations in Chinese early-onset breast cancer patients] | Q81409038 | ||
| Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families | Q81787605 | ||
| Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women | Q81978444 | ||
| Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history | Q82151956 | ||
| BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia | Q82294677 | ||
| BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects | Q82798505 | ||
| Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families | Q83021511 | ||
| BRCA1 and BRCA2 mutations in a South American population | Q83157294 | ||
| Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry | Q83167340 | ||
| Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer | Q83179039 | ||
| Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition | Q83812240 | ||
| Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study | Q83946479 | ||
| Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population | Q84453403 | ||
| High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer | Q84732910 | ||
| BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica | Q84898545 | ||
| A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas | Q85025815 | ||
| Family history, BRCA mutations and breast cancer in Vietnamese women | Q85202430 | ||
| Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel | Q85225896 | ||
| The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families | Q85333965 | ||
| Geographical distribution of Slovenian BRCA1/2 families according to family origin: implications for genetic screening | Q86091543 | ||
| Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer | Q95721725 | ||
| The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas | Q43702401 | ||
| BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics | Q44060672 | ||
| A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history | Q44121032 | ||
| Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalenc | Q44226465 | ||
| BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer. | Q44367712 | ||
| Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population | Q44402415 | ||
| Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from North-East India. | Q44663551 | ||
| Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia | Q44761694 | ||
| De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes | Q44846698 | ||
| BRCA1 mutation analysis in breast/ovarian cancer families from Greece | Q44909070 | ||
| Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer | Q44948551 | ||
| Identification of a novel mutations BRCA1*c.80 + 3del4 and BRCA2*c.6589delA in Slovak HBOC families | Q45232528 | ||
| Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients | Q45807774 | ||
| BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela. | Q45904167 | ||
| BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. | Q45906306 | ||
| High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. | Q46002818 | ||
| Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients | Q46207719 | ||
| Application of multiplex PCR with histopathologic features for detection of familial breast cancer in formalin-fixed, paraffin-embedded histologic specimens. | Q46481907 | ||
| Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups | Q46576514 | ||
| Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba | Q46744547 | ||
| Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. | Q46845832 | ||
| Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation | Q47407492 | ||
| Linking Histopathology and Family History in Breast Cancer | Q47948729 | ||
| Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation | Q48070015 | ||
| Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1. | Q48075608 | ||
| Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer. | Q48234883 | ||
| BRCA1 germline mutations in Indian familial breast cancer | Q48268212 | ||
| Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer | Q48610385 | ||
| A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa | Q48654661 | ||
| The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families | Q48694639 | ||
| Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia | Q24680712 | ||
| Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer | Q24796354 | ||
| How many more breast cancer predisposition genes are there? | Q24800566 | ||
| High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area | Q24813558 | ||
| Haplotype analysis suggest common founders in carriers of the recurrent BRCA2mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families | Q27496673 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Cancer susceptibility and the functions of BRCA1 and BRCA2 | Q28217784 | ||
| Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients | Q28265357 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients | Q28384196 | ||
| Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer | Q28387387 | ||
| Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil | Q28389127 | ||
| Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India | Q33259252 | ||
| BRCA1 and BRCA2 germline mutation analysis in the Indonesian population | Q33304489 | ||
| The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation | Q33313283 | ||
| BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history | Q33330316 | ||
| Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families | Q33337514 | ||
| Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals | Q33355677 | ||
| Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. | Q33368443 | ||
| Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80 | Q33378036 | ||
| Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. | Q33679480 | ||
| Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families | Q33679692 | ||
| The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population | Q33792732 | ||
| BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia | Q33842311 | ||
| Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary | Q33900686 | ||
| The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript | Q33949266 | ||
| Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection | Q34029011 | ||
| BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair | Q34110729 | ||
| Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer | Q34113283 | ||
| Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain | Q34185873 | ||
| The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer | Q34266810 | ||
| Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer | Q34288968 | ||
| Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion | Q34301309 | ||
| BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect | Q34319314 | ||
| Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study | Q34385784 | ||
| A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes | Q34385903 | ||
| Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. | Q34412163 | ||
| Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. | Q34414768 | ||
| The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada | Q34566622 | ||
| BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. | Q34606898 | ||
| Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil | Q34613122 | ||
| Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer | Q34625335 | ||
| On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations | Q34705352 | ||
| Breast and Ovarian Cancer Risk due to Prevalence of BRCA1 and BRCA2 Variants in Pakistani Population: A Pakistani Database Report | Q34923121 | ||
| BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation | Q35006713 | ||
| Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry | Q35029565 | ||
| Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado | Q35184354 | ||
| Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer | Q35238455 | ||
| The effect of a single BRCA2 mutation on cancer in Iceland | Q35440029 | ||
| BRCA1 c.2845insA is a recurring mutation with a founder effect in Singapore Malay women with early onset breast/ovarian cancer | Q35440846 | ||
| BRCA1 in hormone-responsive cancers | Q35546588 | ||
| Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece | Q35619211 | ||
| The genetic epidemiology of breast cancer genes | Q35959353 | ||
| Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study | Q36070055 | ||
| BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1 | Q36115744 | ||
| Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon | Q36232043 | ||
| Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. | Q36245632 | ||
| Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain | Q36417815 | ||
| Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network | Q36494254 | ||
| Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population. | Q36501516 | ||
| TGFBR1 signaling and breast cancer | Q36578568 | ||
| BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer | Q36617295 | ||
| BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients | Q36621949 | ||
| Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review | Q36633089 | ||
| Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families | Q36642880 | ||
| BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families | Q36694756 | ||
| Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. | Q36700472 | ||
| BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases | Q36755039 | ||
| Evidence against PALB2 involvement in Icelandic breast cancer susceptibility | Q36800754 | ||
| Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico | Q36849117 | ||
| Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer | Q36955087 | ||
| Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer | Q37004792 | ||
| BRCA gene structure and function in tumor suppression: a repair-centric perspective. | Q37694209 | ||
| Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation | Q37709882 | ||
| Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer | Q37877648 | ||
| Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population | Q38457675 | ||
| Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. | Q38469992 | ||
| The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim | Q38892074 | ||
| BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants | Q39514959 | ||
| Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. | Q39534663 | ||
| Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India | Q39701378 | ||
| Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers | Q42452703 | ||
| German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene | Q42654026 | ||
| Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer | Q43109041 | ||
| Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). | Q43417392 | ||
| High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia | Q43522641 | ||
| Germline BRCA1 mutations in Iranian women with breast cancer. | Q43542131 | ||
| Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene | Q43638942 | ||
| BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. | Q50547545 | ||
| Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. | Q51293206 | ||
| MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. | Q51705297 | ||
| Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. | Q51752759 | ||
| The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal. | Q52804548 | ||
| Genetic epidemiology of BRCA1 mutations in Norway. | Q53145195 | ||
| Three-hit hypothesis in astrocytoma: tracing the polymorphism D1853N in ATM gene through a pedigree of the proband affected with primary brain tumor. | Q53478659 | ||
| Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation. | Q53500717 | ||
| Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. | Q53665943 | ||
| BRCA1 gene mutations frequency estimation by allele-specific real-time PCR of pooled genomic DNA samples. | Q54273511 | ||
| Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. | Q54279806 | ||
| BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. | Q54348841 | ||
| Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer. | Q54429234 | ||
| Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. | Q54460596 | ||
| Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer. | Q54462431 | ||
| [Prevalence of mutations BRCA1 5382insC, and CHEK2 1100delC in the population of Siberian region]. | Q54486334 | ||
| Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. | Q54633120 | ||
| Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. | Q54694066 | ||
| Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan. | Q54787853 | ||
| The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews | Q56508831 | ||
| Prevalence ofBRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectableBRCA1 andBRCA2 point mutations | Q57056221 | ||
| A DGGE system for comprehensive mutation screening ofBRCA1andBRCA2: application in a Dutch cancer clinic setting | Q57200495 | ||
| Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families | Q57278919 | ||
| A BRCA2 mutation, 4088insA, in a Finnish breast and ovarian cancer family associated with favourable clinical course | Q57278922 | ||
| Clinical Classification ofBRCA1andBRCA2DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis—A Report From the kConFab Investigators | Q57306048 | ||
| Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families | Q57306222 | ||
| Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for br | Q57363991 | ||
| G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history | Q57390836 | ||
| Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy | Q57419725 | ||
| Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing | Q57577799 | ||
| BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer | Q57634603 | ||
| Spectrum and prevalence ofBRCA1 andBRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening | Q57781606 | ||
| Haplotype Analysis of BRCA2 8765delAG Mutation Carriers in French Canadian and Yemenite Jewish Hereditary Breast Cancer Families | Q58325246 | ||
| BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy | Q60170562 | ||
| Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany | Q61970381 | ||
| High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus | Q62583327 | ||
| BRCA2 gene mutations in Slovenian male breast cancer patients | Q64044812 | ||
| BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations | Q71696011 | ||
| Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome | Q73031785 | ||
| Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer | Q73038076 | ||
| Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families | Q73088192 | ||
| Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients | Q73109319 | ||
| Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families | Q73282154 | ||
| Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families | Q73374571 | ||
| Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium | Q73375647 | ||
| Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore | Q73692281 | ||
| Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p | Q73892577 | ||
| BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer | Q74004355 | ||
| Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer | Q74691327 | ||
| Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families | Q75259366 | ||
| Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway | Q75397290 | ||
| BRCA1 and BRCA2 mutations in Russian familial breast cancer | Q77495310 | ||
| Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population | Q77523705 | ||
| Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan | Q77738158 | ||
| BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines | Q77839463 | ||
| Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer | Q77845970 | ||
| Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online | Q78125794 | ||
| Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families | Q78315335 | ||
| BRCA1 and BRCA2 sequence variants in Chinese breast cancer families | Q78545234 | ||
| BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer | Q78847242 | ||
| Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil | Q79298338 | ||
| Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer | Q79353575 | ||
| Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus | Q79652358 | ||
| Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer | Q80240964 | ||
| BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland | Q80243226 | ||
| Promoter methylation of the PTEN gene is a common molecular change in breast cancer | Q80403566 | ||
| [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method] | Q81029752 | ||
| The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified | Q81242004 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | BRCA1 | Q227339 |
| mutation | Q42918 | ||
| BRCA2 | Q17853272 | ||
| breast neoplasm | Q23929670 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 928562 | |
| P577 | publication date | 2013-11-07 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer | |
| P478 | volume | 2013 |
| Q48128057 | A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors |
| Q64062549 | Apolipoprotein A1 and B as risk factors for development of intraocular metastasis in patients with breast cancer |
| Q92889988 | BCScreen: A gene panel to test for breast carcinogenesis in chemical safety screening |
| Q64948494 | BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. |
| Q27002334 | BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African |
| Q35744834 | BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review |
| Q35345684 | BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer |
| Q56335931 | BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso |
| Q46795876 | Breast Cancer Disparities: Socioeconomic Factors versus Biology |
| Q48292951 | Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants |
| Q38633504 | Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions |
| Q91383545 | Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis |
| Q51280306 | Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer. |
| Q40890323 | Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India |
| Q38339360 | Disparities in breast cancer and african ancestry: a global perspective |
| Q36279255 | Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing |
| Q104745075 | Evolutionary demographic models reveal the strength of purifying selection on susceptibility alleles to late-onset diseases |
| Q39449815 | Genetics in an isolated population like Finland: a different basis for genomic medicine? |
| Q49573714 | Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan. |
| Q37032901 | Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer |
| Q57105520 | Male breast cancer: a disease distinct from female breast cancer |
| Q38262826 | Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. |
| Q55085561 | Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients. |
| Q41696477 | Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer. |
| Q51257152 | New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families. |
| Q38691342 | Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women. |
| Q64951109 | Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients. |
| Q26851765 | Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition |
| Q37668511 | PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting |
| Q31159863 | Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. |
| Q98177856 | Patterns and Prevalence of Germline BRCA1 and BRCA2 Mutations among High-Risk Breast Cancer Patients in Jordan: A Study of 500 Patients |
| Q40321595 | Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population |
| Q60918179 | Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors |
| Q49829001 | Role of BRCA Mutations in the Modulation of Response to Platinum Therapy. |
| Q39254699 | SNM1B/Apollo in the DNA damage response and telomere maintenance |
| Q64258039 | Single gold-bridged nanoprobes for identification of single point DNA mutations |
| Q36161162 | The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine |
| Q34263334 | Transcriptional profiling and dynamical regulation analysis identify potential kernel target genes of SCYL1-BP1 in HEK293T cells |
| Q38411443 | Triple-negative breast cancer in Ghanaian women: The Korle Bu Teaching Hospital experience |
| Q35609850 | Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing |
Search more.